Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Conditions: Ovarian Cancer Interventions: Genetic: Biomolecular profiling Sponsors: University of Helsinki; Helsinki University Central Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy
Conditions: Ovarian Cancer Interventions: Procedure: Laparoscopy Sponsors: Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
Conditions: Recurrent Ovarian Cancer; Recurrent Uterine Cancer; Metastatic Cancer; Advanced Cancer Interventions: Drug: RP-6306; Drug: Carboplatin; Drug: Paclitaxel Sponsors: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
Conditions: Ovarian Tumor; Ovarian Cancer Interventions: Other: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasound in according with the IOTA definitions is performed. Sponsors: Maxima Medical Center; Radboud University Medical Center; The Netherlands Cancer Institute; Catharina Ziekenhuis Eindhoven; ZonMw: The Netherlands Organisation for Health Research and Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery
Conditions: Ovarian Neoplasm Epithelial Interventions: Other: acute normovolemic hemodilution (ANH); Other: acute hypervolemic hemodilution (AHH) Sponsors: Zhejiang Cancer Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
Conditions: Ovarian Cancer Recurrent Interventions: Drug: Fluzopril Combined With Apatinib Sponsors: Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Conditions: Cancer; Tumor, Solid; Malignant Neoplasm; Metastatic Cancer; Advanced Solid Tumor; Platinum-resistant Ovarian Cancer; Cutaneous Squamous Cell Carcinoma Interventions: Drug: OR502; Drug: Cemiplimab Sponsors: OncoResponse, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer Interventions: Drug: Niraparib Sponsors: Asan Medical Center; Samsung Medical Center; Seoul National University Hospital; Severance Hospital; Gangnam Severance Hospital; Keimyung University Dongsan Medical Center; Kyungpook National University Chilgok Hospital; Seoul St. Mary ' s Hospital; National Cancer Center, Korea; Pusan National University Yangsan Hospital; Inje University; Pusan National University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Drug: KAND567; Drug: Carboplatin Sponsors: Kancera AB; Nordic Society of Gynaecological Oncology - Clinical Trials Unit Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Patients Derived Organoids in Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Procedure: Blood sample Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Conditions: Epithelial Ovarian Cancer Interventions: Diagnostic Test: Hematologic features Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
A Phase Ib Study of Sovilnesib in Subjects With Ovarian Cancer
Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
Conditions: Ovarian Cancer Interventions: Drug: Pembrolizumab; Drug: Bevacizumab; Drug: Cyclophosphamide Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
Conditions: High Grade Serous Ovarian Cancer Interventions: Biological: Blood sample and tissue sample Sponsors: Institut du Cancer de Montpellier - Val d ' Aurelle Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
A Study of Sovilnesib in Subjects With Ovarian Cancer
Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
